Literature DB >> 24844212

Histone post-translational modifications induced by histone deacetylase inhibition in transcriptional control units of NIS gene.

Federica Baldan1, Elisa Lavarone, Carla Di Loreto, Sebastiano Filetti, Diego Russo, Giuseppe Damante, Cinzia Puppin.   

Abstract

Histone post-translational modifications (HPTMs) play a major role in control of gene transcription. Among them, histone acetylation and methylation have been extensively investigated. Histone acetylation at different residues is generally associated to active gene transcription. In contrast, histone methylation can be associated either to transcriptional activation or repression, depending primarily on the histone residue that is subjected to the modification. Herein, effects of the histone deacetylase inhibitor SAHA on the sodium-iodide symporter (NIS) gene expression were investigated in breast cancer cells (MDA157 and MDA468). SAHA treatment induces high increase of NIS mRNA levels in MDA468 cells (300-fold), but moderate increase in MDA157 cells (fivefold). Histone H3 HPTMs (acetylation and methylations) on transcriptional units of NIS gene were investigated in these cell lines upon SAHA treatment. Our data indicate that HPTMs, particularly the H3 lysine 27 trimethylation, may operate in contrast to current models that relate epigenetic modifications with transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24844212     DOI: 10.1007/s11033-014-3397-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  30 in total

Review 1.  Global patterns of histone modifications.

Authors:  Oliver J Rando
Journal:  Curr Opin Genet Dev       Date:  2007-02-20       Impact factor: 5.578

2.  High-resolution profiling of histone methylations in the human genome.

Authors:  Artem Barski; Suresh Cuddapah; Kairong Cui; Tae-Young Roh; Dustin E Schones; Zhibin Wang; Gang Wei; Iouri Chepelev; Keji Zhao
Journal:  Cell       Date:  2007-05-18       Impact factor: 41.582

Review 3.  Histone acetylation in chromatin structure and transcription.

Authors:  M Grunstein
Journal:  Nature       Date:  1997-09-25       Impact factor: 49.962

4.  The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS).

Authors:  N Fortunati; M G Catalano; F Marano; V Mugoni; M Pugliese; O Bosco; F Mainini; G Boccuzzi
Journal:  Breast Cancer Res Treat       Date:  2010-03-09       Impact factor: 4.872

Review 5.  Discovery and development of SAHA as an anticancer agent.

Authors:  P A Marks
Journal:  Oncogene       Date:  2007-02-26       Impact factor: 9.867

Review 6.  The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.

Authors:  Takahiko Kogai; Gregory A Brent
Journal:  Pharmacol Ther       Date:  2012-06-29       Impact factor: 12.310

7.  The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines.

Authors:  Elisa Lavarone; Cinzia Puppin; Nadia Passon; Sebastiano Filetti; Diego Russo; Giuseppe Damante
Journal:  Mol Cell Endocrinol       Date:  2012-09-05       Impact factor: 4.102

8.  A thyroid-specific far-upstream enhancer in the human sodium/iodide symporter gene requires Pax-8 binding and cyclic adenosine 3',5'-monophosphate response element-like sequence binding proteins for full activity and is differentially regulated in normal and thyroid cancer cells.

Authors:  Katsumi Taki; Takahiko Kogai; Yoko Kanamoto; Jerome M Hershman; Gregory A Brent
Journal:  Mol Endocrinol       Date:  2002-10

9.  Ras-induced changes in H3K27me3 occur after those in transcriptional activity.

Authors:  Masaki Hosogane; Ryo Funayama; Yuichiro Nishida; Takeshi Nagashima; Keiko Nakayama
Journal:  PLoS Genet       Date:  2013-08-29       Impact factor: 5.917

10.  Comparative analyses of H3K4 and H3K27 trimethylations between the mouse cerebrum and testis.

Authors:  Peng Cui; Wanfei Liu; Yuhui Zhao; Qiang Lin; Daoyong Zhang; Feng Ding; Chengqi Xin; Zhang Zhang; Shuhui Song; Fanglin Sun; Jun Yu; Songnian Hu
Journal:  Genomics Proteomics Bioinformatics       Date:  2012-06-09       Impact factor: 7.691

View more
  3 in total

1.  MCM5 as a target of BET inhibitors in thyroid cancer cells.

Authors:  Catia Mio; Elisa Lavarone; Ketty Conzatti; Federica Baldan; Barbara Toffoletto; Cinzia Puppin; Sebastiano Filetti; Cosimo Durante; Diego Russo; Arturo Orlacchio; Antonio Di Cristofano; Carla Di Loreto; Giuseppe Damante
Journal:  Endocr Relat Cancer       Date:  2016-02-24       Impact factor: 5.678

2.  Epigenetic Modifications in Thyroid Cancer Cells Restore NIS and Radio-Iodine Uptake and Promote Cell Death.

Authors:  Sabine Wächter; Alexander I Damanakis; Moritz Elxnat; Silvia Roth; Annette Wunderlich; Frederik A Verburg; Sebastian A Fellinger; Detlef K Bartsch; Pietro Di Fazio
Journal:  J Clin Med       Date:  2018-03-21       Impact factor: 4.241

3.  Enhancement of human sodium iodide symporter gene therapy for breast cancer by HDAC inhibitor mediated transcriptional modulation.

Authors:  Madhura G Kelkar; Kalimuthu Senthilkumar; Smita Jadhav; Sudeep Gupta; Beyong-Cheol Ahn; Abhijit De
Journal:  Sci Rep       Date:  2016-01-18       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.